High frequency of aberrant p16(INK4A) expression in human breast cancer

J Geradts1, P A Wilson

  • 1Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, USA.

Insights

Aberrant p16(INK4A) expression is common in breast cancer. This cell cycle regulator, encoded by the CDKN2/MTS1 gene, is frequently inactivated, impacting tumor development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • The CDKN2/MTS1 gene product, p16(INK4A), is a crucial negative cell cycle regulator that inhibits retinoblastoma protein (pRB) phosphorylation.
  • Inactivation of p16(INK4A) is observed in various human malignancies, including breast cancer, suggesting its role in tumorigenesis.

Purpose of the Study:

  • To investigate the expression patterns of p16(INK4A) and pRB in a cohort of archival breast tumors.
  • To determine the frequency and potential correlations of aberrant p16(INK4A) expression with histopathological features in breast cancer.

Main Methods:

  • Immunohistochemistry was employed to assess the expression levels of p16(INK4A) and pRB proteins in 104 archival breast tumor specimens.
  • Tumor specimens included ductal, lobular, and mixed carcinomas, with evaluation for both protein expression and abnormalities.

Main Results:

  • While retinoblastoma protein (pRB) expression was largely normal (only 6 tumors showed abnormalities), a significant proportion of breast carcinomas exhibited abnormal p16(INK4A) expression.
  • Approximately 49% of the 87 interpretable cases (43 tumors) were completely or focally negative for p16(INK4A).
  • No significant correlation was found between abnormal p16(INK4A) expression and common histopathological parameters.

Conclusions:

  • Aberrant p16(INK4A) expression, particularly loss of expression, is a frequent molecular abnormality in human breast cancer.
  • The findings highlight the potential significance of p16(INK4A) dysregulation in the pathogenesis of breast cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...